Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Great Presetation today

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Toinv

Rank: President [?]

Points: 4445 [?]

Votes: 35 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Great Presetation today - Transcript

in response to

Re: Great Presetation today - Transcript

imtesty

posted on Oct 26, 2017 10:28AM

Thanks imtesty.

Does anyone recall any questions during the presentation? Don did not seem to invite questions at the end.